Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 3/20 | 0.47 |
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.40 |
| ▸ | CPA1 | P15085 | 2/20 | 0.40 |
| ▸ | CPA3 | P15088 | 2/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | CPB1 | P15086 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2991859 | 0.84 | LAP3 (0.50) | LAP3ANPEPACP3CYP1A2ALPI | |
| SCHEMBL2991862 | 0.84 | LAP3 (0.50) | LAP3ANPEPACP3CYP1A2ALPI | |
| Ammonia Solution, Strong SCHEMBL2415756 | 0.83 | LAP3 (0.46) | LAP3ANPEPACP3CYP1A2ALPI | |
| SCHEMBL9137977 | 0.83 | LAP3 (0.49) | LAP3ANPEPACP3CYP1A2ALPI | |
| SCHEMBL9137969 | 0.83 | LAP3 (0.49) | LAP3ANPEPACP3CYP1A2ALPI | |
| SCHEMBL288097 | 0.78 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL475786 | 0.78 | CYP1A2 (0.55) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL14637889 | 0.77 | CYP1A2 (0.50) | LAP3ANPEPACP3CYP1A2ALPI | |
| SCHEMBL14637890 | 0.77 | CYP1A2 (0.50) | LAP3ANPEPACP3CYP1A2ALPI | |
| Phosphoric Acid SCHEMBL28045535 | 0.77 | CYP1A2 (0.50) | LAP3ANPEPACP3CYP1A2ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994008600-A1 | INHIBITION OF SIGNAL TRANSDUCTION MOLECULES | JOSLIN DIABETES CENTER (US) | 1994-04-28 | — | — | WO | claimed |
| US-20180264080-A1 | TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION | KINETA ONE, LLC (US) | 2018-09-20 | — | — | US | disclosed |
| US-9937230-B2 | Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof | KINETA ONE, LLC (US) | 2018-04-10 | — | — | US | disclosed |
| US-20160338967-A1 | SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF | KINETA ONE, LLC (US) | 2016-11-24 | — | — | US | disclosed |
| EP-3086779-A2 | SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF | Kineta One, LLC (US) | 2016-11-02 | — | — | EP | disclosed |
| WO-2016112208-A2 | TOPICAL APPLICATIONS OF KV1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION | KINETA ONE, LLP (US) | 2016-07-14 | — | — | WO | disclosed |
| US-20160151457-A1 | OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF | KINETA ONE, LLC (US) | 2016-06-02 | — | — | US | disclosed |
| EP-3024472-A2 | OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Kineta One, LLC (US) | 2016-06-01 | — | — | EP | disclosed |
| WO-2015100370-A2 | SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF | KINETA ONE, LLC (US) | 2015-07-02 | — | — | WO | disclosed |
| WO-2015013330-A2 | OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF | KINETA ONE, LLC (US) | 2015-01-29 | — | — | WO | disclosed |
| US-5801149-A | PEPTIDS FOR INHIBITION OF PROTEINS | JOSLIN D-ABETES CENTER, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| US-5475129-A | Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-12-12 | — | — | US | disclosed |
| WO-1994008600-A1 | INHIBITION OF SIGNAL TRANSDUCTION MOLECULES | JOSLIN DIABETES CENTER (US) | 1994-04-28 | — | — | WO | disclosed |
| WO-1993025561-A1 | PHOSPHONOALKYL PHENYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-12-23 | — | — | WO | disclosed |
| US-5264607-A | Process of making benzylic α,α-diflurophosphonates from benzylic α-ketophosphorates | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-11-23 | — | — | US | disclosed |